Menu

去纤苷(去纤维钠)去哪可以买到?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

It is currently the most effective drug for the treatment of hepatic veno-occlusive disease (HOVD) after hematopoietic stem cell transplantation (HSCT).

Based on its anticoagulant, fibrinolysis-promoting, and anti-inflammatory effects, its application in the treatment of HVOD after HSCT was explored. This study included 19 sHOVD patients. The dosage of defibrotide is 5~60mg/kg per day, intravenous infusion, and the median usage time is 15d (2-61d).

The results showed that 42% of patients achieved complete remission (CR), and the overall survival (os) rate 100 days after transplantation reached 32%, and patients could tolerate defibrotide well. Since then, multiple clinical trials have confirmed the effectiveness of defibrotide in the treatment of HVOD.

So, where can I buy defibrotide (sodium defibrotide) with such a good therapeutic effect?

Purchasing channels for defibrotide: It is understood that defibrotide has not been officially launched in China yet. Patients in need can purchase the version available abroad. When it comes to buying medicine, the first thing that comes to mind is the price.

Defibrinoside, which is marketed abroad, has a specification of 200 mg and is priced around $20,000. Due to exchange rate fluctuations, the price may vary. Please consult Medical Travel for specific prices!

If you want to buy defibrotide that is marketed abroad and it is inconvenient to go abroad, the most reliable way is to buy it through a formal overseas medical service institution in China, which will sign a guarantee contract for you. The medicine and money will not be handled, and will be mailed to the patient by direct mail, guaranteeing 100% authenticity!

Hypersensitivity reactions may occur with the use of defibrotides:

Hypersensitivity reactions have occurred in less than 2% of patients treated with defibrotide. These reactions include rash, urticaria, and angioedema. One case of allergic reaction was reported in a patient who had previously received defibrotide. Monitor patients for hypersensitivity reactions. Especially if there is a history of previous exposure. If a severe hypersensitivity reaction occurs, discontinue, treat with standard medical care, and monitor until symptoms resolve.

Recommended related hot articles: /newsDetail/81065.html

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。